United States Psychedelic Mushroom Market Size, Share, and COVID-19 Impact Analysis, By Product Type (Psilocybe, Gymnopilus, and Panaeolus), By Form (Fresh, Dried, and Processed), By Application (Depression Relief, Anxiety Relief, De-addiction, Recreational, and Others), and United States Psychedelic Mushroom Market Insights, Industry Trend, Forecasts To 2035

United States Psychedelic Mushroom Market Insights Forecasts to 2035

• The United States Psychedelic Mushroom Market Size Was Estimated at USD 3.22 Billion in 2024
• The Market Size is Expected to Grow at a CAGR of around 12.09% from 2025 to 2035
• The United States Psychedelic Mushroom Market Size is Expected to Reach USD 11.3 Billion by 2035

According to a research report published by Spherical Insights & Consulting, The United States Psychedelic Mushroom Market Size is anticipated to reach USD 11.3 Billion by 2035, growing at a CAGR of 12.09% from 2025 to 2035. The U.S. psychedelic mushroom market is being driven by the decriminalization of the use of psychedelic mushrooms, as well as other plant-based entheogens. Several cities and states have already taken steps to decriminalize or legalize the use of these substances, which has led to increased interest and demand.

Market Overview 

Psychedelic mushrooms are naturally occurring fungi that contain psychoactive substances such as cytosine and psilocin, shown to affect mood, perception, and thought processes. Many civilizations, especially in Central and South America, have used these mushrooms for ages in their ancient spiritual and medical rituals. Due to his potential therapeutic uses in contemporary medicine, they are currently attracting increased scientific and professional interest. Psilocin, which interacts with serotonin receptors in the brain, is produced when psilocybin is consumed. Sensory perception, better introspection, an increase in mood, and sometimes changes in mysterious or spiritual experiences are among the converted states of consciousness brought by this interaction. The development of the next generation of psychiatric drugs focuses on psychedelic mushrooms due to the encouraging results of controlled studies in prestigious universities and medical facilities. In areas where rules are loose, mushrooms are still largely limited to research, clinical trials, and welfare industries. In some American states and other countries, medical use and regulated items are becoming more accessible as a result of decriminalization and legalization movements. While nutraceuticals and wellness sectors are checking functional mushroom mixtures that support cognitive and digestive health without producing psychedelic effects, startups and pharmaceutical corporations are important investments in making psilocybin-based drugs.

Report Coverage 

This research report categorizes the USA psychedelic mushroom market based on various segments and regions, and forecasts revenue growth and analyses trends in each submarket. The report analyses the key growth drivers, opportunities, and challenges influencing the USA psychedelic mushroom market. Recent market developments and competitive strategies, such as expansion, type launch, development, partnership, merger, and acquisition, have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key market players and analyses their core competencies in each sub-segment of the USA psychedelic mushroom market. 

Driving Factor

The United States psychedelic mushroom market is driven by increased body, anxiety, and increased rate of sadness, and encouraging clinical testing conclusions of psilocybin on mental health treatments. The market is expanding more rapidly due to the government-led radical efforts, increasing acceptance of alternative medicine, and investments from pharmaceutical firms and wellness start-ups.

Restraining Factor 

The United States psychedelic mushroom market has to face restrictions due to widely adoption is interrupted by security concerns about tough legal boundaries, social stigma, and uncontrolled consumption. Compassionate in strict legal framework areas are delayed due to moral discussion about high R&D expenses, FDA approval, and recreational versus medical use.

The United States psychedelic mushroom market share is classified into product type, form, and application.

• The psilocybe segment held the largest market share in 2024 and is expected to grow at a significant CAGR during the projected timeframe.

The United States psychedelic mushroom market is segmented by product type into psilocybe, gymnopilus, and panaeolus. Among these, the psilocybe segment held the largest market share in 2024 and is expected to grow at a significant CAGR during the projected timeframe. This is due to interest in natural and overall health methods, transferring perceptions of psychedelic drugs, and more research into their ability as medical.

• The dried segment held the largest market share in 2024 and is anticipated to grow at a significant CAGR during the forecast period. 

The United States psychedelic mushroom market is segmented by form into fresh, dried, and processed. Among these, the dried segment held the largest market share in 2024 and is anticipated to grow at a significant CAGR during the forecast period. This is due to dried cycadic mushrooms being widely used as they are seen as a safe and natural way to achieve altered states of consciousness. In addition, the potentially medicinal benefits of psilocybin have attracted more attention, which may contribute to some demand for these mushrooms.

• The recreational segment dominated the market in 2024 and is expected to grow at a significant CAGR during the forecast period. 

The United States psychedelic mushroom market is segmented by application into depression relief, anxiety relief, de-addiction, recreational, and others. Among these, the recreational segment held the largest market share in 2024 and is expected to grow at a significant CAGR during the forecast period. This growth is driven by increasing cultural acceptance, rising demand for natural hallucinogens, and expanding legalization in some states. Recreational use dominates over medical applications like depression and anxiety relief, making it the leading application area.

Competitive Analysis 

The report offers the appropriate analysis of the key organizations/companies involved within the United States psychedelic mushroom market, along with a comparative evaluation primarily based on their type of offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes type development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market. 

List Of Key Companies

• Shroomland
• Galaxy Treats
• Blissmushrooms
• oneupmushroomsbar.com
• Psychedelic Mushy
• Psilocybin Lounge
• Others

Key Target Audience 

• Market Players
• Investors
• End-users
• Government Authorities
• Consulting And Research Firm
• Venture capitalists
• Value-Added Resellers (VARs)

Market Segment

This study forecasts revenue at the United States, regional, and country levels from 2020 to 2035. Spherical Insights has segmented the United States psychedelic mushroom market based on the below-mentioned segments:

United States Psychedelic Mushroom Market, By Product Type

• Psilocybe
• Gymnopilus
• Panaeolus

United States Psychedelic Mushroom Market, By Form

• Fresh
• Dried
• Processed

United States Psychedelic Mushroom Market, By Application

• Depression Relief
• Anxiety Relief
• De-Addiction
• Recreational
• Others